Tonix CD40L MAb Shows Promise in Kidney Transplant Rejection
Tonix Pharmaceuticals announced positive topline results from its Phase 1 single ascending dose trial of TNX-1500, an anti-CD40L monoclonal...
eClinical Tech News
Trinity Biotech CGM Trial Shows Landmark First-Day Accuracy Gains
Trinity Biotech announced positive findings from a pre-pivotal trial of its next-generation continuous glucose monitoring (CGM) system, demonstrating significant...
Northwestern Medicine First in Aclarion’s Clarity Trial
Aclarion, Inc. launched its pivotal CLARITY trial at Northwestern Medicine, a leading clinical trial research center. The CLARITY trial...
FDA Approves Lipella’s LP-310 for Oral Lichen Planus
Lipella Pharmaceuticals (Nasdaq: LIPO) has received FDA approval for an Expanded Access Program (EAP) for LP-310, an oral rinse...
BioXcel: Business & Clinical Update
BioXcel Therapeutics provided an update on its late-stage clinical trials for BXCL501, a drug for acute agitation, and highlighted...
Zenocutuzumab Efficacy in NRG1+ Cancer: Groundbreaking Results
Merus N.V. announced that the New England Journal of Medicine (NEJM) published positive results from the phase 2 eNRGy...
Ziftomenib Shows Promise in AML Monotherapy & Combination Trials
Kura Oncology and Kyowa Kirin announced positive topline results from the KOMET-001 Phase 2 trial of ziftomenib, an oral...
Arbor Biotechnologies’ ABO-101 Gets FDA Orphan Drug, Rare Pediatric Disease Designations
Arbor Biotechnologies received Orphan Drug and Rare Pediatric Disease designations from the U.S. FDA for ABO-101, a gene editing...
Study Shows ux111 Gene Therapy Improves Clinical Function in Children with Sanfilippo Syndrome Type A
Ultragenyx Pharmaceutical announced positive data from its pivotal and long-term follow-up studies of UX111 (ABO-102), a gene therapy for...
Annovis’ Buntanetap Enters Phase 3 Alzheimer’s Study
Annovis Bio has initiated its pivotal Phase 3 trial for buntanetap, an oral drug candidate for early-stage Alzheimer’s diseaseAlzheimer’s...